Key facts
- This page summarizes Palo Alto Investors LP's Form 4 filing for ALIMERA SCIENCES INC.
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Mar 2023, 17:13.
Palo Alto Investors LP - 24 Mar 2023 Form 4 Insider Report for ALIMERA SCIENCES INC
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 24 Mar 2023
- Net transaction value
- -$1,252,157
- Reporting owner signature
- /s/ Angela Nguyen-Dinh, Chief Compliance Officer of Palo Alto Investors LP
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Palo Alto Investors LP filed Form 4 for ALIMERA SCIENCES INC on 28 Mar 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$1,252,157.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALIM
transaction
Common Stock
Sale
- Transaction value
- $314,117
- Shares
- -200,919
- Change %
- -100%
- Price
- $1.56
- Shares after
- 0
- Date
- 24 Mar 2023
- Ownership
- See note
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALIM
transaction
Derivative
Series A Convertible Preferred Stock
Sale
- Transaction value
- $938,040
- Shares
- -600,000
- Change %
- -100%
- Price
- $1.56
- Shares after
- 0
- Date
- 24 Mar 2023
- Ownership
- See note
- Underlying class
- Common Stock
- Underlying amount
- 601,502
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Palo Alto Investors LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Palo Alto Investors LP ("PAI") is the investment adviser to private funds, including Palo Alto Healthcare Master Fund, L.P. and Palo Alto Healthcare Master Fund II, L.P. (collectively, the "Funds"). Anthony Joonkyoo Yun, MD and Patrick Lee, MD are the managers and controlling owners of PAI. PAI may be deemed to indirectly beneficially own these securities as the investment adviser to the Funds. Dr. Yun and Dr. Lee may be deemed to indirectly beneficially own them as the control persons of PAI. No single Fund owns more than 10% of the outstanding shares of Common Stock. The reporting person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein.
Footnote F2
Each share of Series A Convertible Preferred Stock is convertible into shares of common stock at the rate equal to $40.00 divided by $39.90. The Series A Convertible Preferred Stock does not have an expiration date.